Page last updated: 2024-12-07

dysprosium dtpa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dysprosium DTPA, also known as dysprosium diethylenetriaminepentaacetic acid, is a chelate complex of dysprosium(III) with the ligand diethylenetriaminepentaacetic acid (DTPA). It is a paramagnetic compound that exhibits strong magnetic susceptibility. Dysprosium DTPA is synthesized by reacting dysprosium(III) chloride with DTPA in aqueous solution. It is typically used in magnetic resonance imaging (MRI) as a contrast agent due to its paramagnetic properties, which enhance the contrast between different tissues in the body. Dysprosium DTPA's paramagnetism arises from the unpaired electrons in the dysprosium(III) ion. This paramagnetism allows it to interact with the magnetic field used in MRI, altering the signal intensity and providing enhanced imaging of specific tissues. It is studied due to its potential use in various medical applications, including diagnosis and treatment of diseases. The high magnetic susceptibility of dysprosium DTPA enables it to be used as a contrast agent in MRI, enhancing the visualization of anatomical structures and highlighting abnormalities. However, it is important to note that dysprosium DTPA is not used in routine clinical practice. Further research is ongoing to explore its safety and efficacy in different clinical settings.'

dysprosium DTPA: RN given refers to di-Na salt; RN for parent cpd not available 6/88 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122018
MeSH IDM0157026

Synonyms (6)

Synonym
dysprosium dtpa
92923-41-6
dysprosate(2-), (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, disodium
dy-dtpa
dy(dtpa)2-
disodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;dysprosium(3+)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.00)18.7374
1990's18 (72.00)18.2507
2000's6 (24.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.54 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.84 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]